These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26918338)

  • 1. miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.
    Bijnsdorp IV; Hodzic J; Lagerweij T; Westerman B; Krijgsman O; Broeke J; Verweij F; Nilsson RJ; Rozendaal L; van Beusechem VW; van Moorselaar JA; Wurdinger T; Geldof AA
    Oncotarget; 2016 Mar; 7(13):16676-87. PubMed ID: 26918338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
    Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
    Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
    Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
    J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 9. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
    Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
    J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
    Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
    Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
    PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110.
    Li J; D'Angiolella V; Seeley ES; Kim S; Kobayashi T; Fu W; Campos EI; Pagano M; Dynlacht BD
    Nature; 2013 Mar; 495(7440):255-9. PubMed ID: 23486064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-129-3p controls cilia assembly by regulating CP110 and actin dynamics.
    Cao J; Shen Y; Zhu L; Xu Y; Zhou Y; Wu Z; Li Y; Yan X; Zhu X
    Nat Cell Biol; 2012 Jun; 14(7):697-706. PubMed ID: 22684256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
    Xia L; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W; Sha J
    Biomed Pharmacother; 2020 Apr; 124():109863. PubMed ID: 31986411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer.
    Ganapathy K; Staklinski S; Hasan MF; Ottman R; Andl T; Berglund AE; Park JY; Chakrabarti R
    Sci Rep; 2020 Mar; 10(1):5167. PubMed ID: 32198489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer.
    Liu J; Quan Z; Gao Y; Wu X; Zheng Y
    Biochem Biophys Res Commun; 2021 Oct; 576():73-79. PubMed ID: 34482026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.
    Bakkar A; Alshalalfa M; Petersen LF; Abou-Ouf H; Al-Mami A; Hegazy SA; Feng F; Alhajj R; Bijian K; Alaoui-Jamali MA; Bismar TA
    Mol Biol Rep; 2016 Apr; 43(4):229-40. PubMed ID: 26907180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer.
    Sun F; Wu K; Yao Z; Mu X; Zheng Z; Sun M; Wang Y; Liu Z; Zhu Y
    Aging (Albany NY); 2020 Jun; 12(12):11500-11516. PubMed ID: 32554858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5.
    Fan J; Du W; Zhang H; Wang Y; Li K; Meng Y; Wang J
    FEBS Lett; 2020 Feb; 594(3):466-476. PubMed ID: 31562641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.